The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

BACKGROUND AND OBJECTIVES: The calcimimetic cinacalcet reduced the risk of death or cardiovascular (CV) events in older, but not younger, patients with moderate to severe secondary hyperparathyroidism (HPT) who were receiving hemodialysis. To determine whether the lower risk in younger patients migh...

Full description

Saved in:
Bibliographic Details
Published in:Clin J Am Soc Nephrol
Main Authors: Parfrey, Patrick S., Drüeke, Tilman B., Block, Geoffrey A., Correa-Rotter, Ricardo, Floege, Jürgen, Herzog, Charles A., London, Gerard M., Mahaffey, Kenneth W., Moe, Sharon M., Wheeler, David C., Kubo, Yumi, Dehmel, Bastian, Goodman, William G., Chertow, Glenn M.
Format: Artigo
Language:Inglês
Published: American Society of Nephrology 2015
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4422239/
https://ncbi.nlm.nih.gov/pubmed/25710802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07730814
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items